• Academic Staff

      Professor Ahmet Ata Özçimen
    Profile
    :
    Department
    :
    Faculty of Science .
    Business Address
    :
    Mersin Üniversitesi Fen Fakültesi Çiftlikköy Kampüsü 33343 Yenişehir/ Mersin .
    Phone
    :
    +90 -324-3610001 .
    Internal
    :
    14829 .
    Fax
    :
    +90 -324-3610047 .
    URL
    :
    VCARD
    :
    Created
    :
    2015-05-28 16:09:30 .
    Last Modification
    :
    2024-06-07 14:19:49 .
    Researcher ID :
    F-8161-2015
    Scopus ID :
    35485258000
    Orcid ID :
    0000-0002-8871-8943
    Scholar ID :
    eQbsKoMAAAAJ
    h-index :
    4
    Publons ID :
    Point :
    32606

    Degree Department/Program Institute Year
    1993
    MASTER OF MEDICAL SCIENCE CLINICAL ONCOLOGY UNIVERSITY OF SHEFFIELD / INSTITUTE FOR CANCER STUDIES 1995
    2005

    Doctorate Thesis

    1. The Effect of Steroid on the Apoptosis and Differentiation in HL-60 (Human Acute Myeloid Leukemia) Cell Line, Supervisor: Dr. Ahmet KART, Hacettepe University, Graduate School of Health Sciences, Medical Biology Department, Ankara, Turkey, 2005.

    Master Thesis

    1. An Analaysis of the Cytotoxic Cell Cycle Analysis of Novel Antitumor Compounds, Supervisor: Dr. John LAWRY, Others, Others, Other Department, Sheffield, England / United Kingdom, 1995.

    Title Institute Year
    PROFFESOR MERSIN UNIVERSITY 2022-08-12 - 2022-08-12
    ASS. PROF. MERSIN UNIVERSITY 2008-03-06 - Continue
    ASSOC. PROF. DR. MERSIN UNIVERSITY 2016-04-04 - Continue

    Title Dutie Institution/Other Year
    2018-03-26 - 2021-03-26
    2018-03-26 - 2021-03-26
    2018-03-26 - 2021-03-26
    2017-11-14 - 2020-11-14
    2017-11-14 - 2020-11-14
    2017-02-24 - 2020-02-24
    2017-02-24 - 2020-02-24
    2010-12-27 - 2013-12-27

    International - Covered by ULAKBIM 0
    2020
    1. doğan, h.; SİLİCİ, S.; ÖZÇİMEN, A. . TURK TARIM - GIDA BILIM VE TEKNOLOJI DERGISI, 2020, 8, 573-579. 0 + 0
    International - SCI/SCI-Expanded category 9150
    2024
    12. ALABAŞ, E.; ÖZÇİMEN, A. . TURKISH JOURNAL OF GASTROENTEROLOGY, 2024, 35, 150-157. 1000 + 0
    10.5152/tjg.2024.22319

    11. DOĞAN, H.; ÖZÇİMEN, A.; SİLİCİ, S. . MOLECULAR BIOLOGY REPORTS, 2024, 51, 551-559. 1000 + 0
    10.1007/s11033-024-09493-7

    2020
    10. KIRBIYIK, I.; ÖZÇİMEN, A. . JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 0, 0-. 1000 + 0
    10.4103/jcrt.JCRT_827_19

    2015
    9. Unal, S.; Ozdemir, O.; Ozcimen, A.; Oztas, Y. Increase of serum fractalkine and fractalkine gene expression levels in sickle cell disease patients. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 101, 114-118. 750 + 0
    https://dx.doi.org/10.1007/s12185-014-1718-4

    8. ÜNAL, S.; ÖZDEMİR, Ö.; ÖZÇİMEN, A.; ER ÖZTAŞ, Y. . INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 101, 114-118. 750 + 0
    10.1007/s12185-014-1718-4

    2014
    7. Ozcimen, A.; Unal, S.; Canacankatan, N.; Antmen, S. Tumor Necrosis Factor-Superfamily 15 Gene Expression in Patients with Sickle Cell Disease. TURKISH JOURNAL OF HEMATOLOGY, 2014, 31, 255-260. 950 + 0
    https://dx.doi.org/10.4274/tjh.2012.0130

    2013
    6. Yucel, A.; Dilek, K.; Saba, D.; Ozcimen, A.; Yurtkuran, M.; Oral, H. Interleukin-2 gene polymorphism in Turkish patients with Behcet's disease and its association with ocular involvement. INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2013, 40, 349-355. 550 + 15
    https://dx.doi.org/10.1111/iji.12039


    Times Cited: 3
    5. YÜCEL, A.; DİLEK, K.; SABA, D.; ÖZÇİMEN, A.; ORAL, H. . INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2013, 40, 349-355. 600 + 0
    2011
    4. ÖZÇİMEN, A.; DİLEK, K.; BİNGÖL, Ü.; SARICAOĞLU, H.; SARANDÖL, A.; TAŞKAPILIOĞLU, Ö.; YURTKURAN, D.; YURTKURAN, M.; ORAL, H. . INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2011, 38, 295-301. 700 + 0
    3. Oral, H.; Dilek, K.; Ozcimen, A.; Taskapilioglu, O.; Bingol, U.; Sarandol, A.; Saricaoglu, H.; Yurtkuran, M.; Yurtkuran, M. Interleukin-4 Gene Polymorphisms Confer Behcet's Disease in Turkish Population. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2011, 73, 594-601. 500 + 53
    https://dx.doi.org/10.1111/j.1365-3083.2011.02532.x


    Times Cited: 10
    2. Ozcimen, A.; Dilek, K.; Bingol, U.; Saricaoglu, H.; Sarandol, A.; Taskapilioglu, O.; Yurtkuran, M.; Yurtkuran, M.; Oral, H. IL-1 cluster gene polymorphisms in Turkish patients with Behcet's disease. INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2011, 38, 295-301. 700 + 67
    https://dx.doi.org/10.1111/j.1744-313X.2011.01006.x


    Times Cited: 11
    2009
    1. Dilek, K.; Ozcimen, A.; Saricaoglu, H.; Saba, D.; Yucel, A.; Yurtkuran, M.; Yurtkuran, M.; Oral, H. Cytokine gene polymorphisms in Behcet's disease and their association with clinical and laboratory findings. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27, 73-78. 650 + 114

    Times Cited: 18
    International - Other 45
    2020
    1. ALAKAYA, M.; ÇITAK, E.; TAŞKINLAR, S.; YILMAZ, Ş.; ÖZÇİMEN, A.; ÇİMEN, M. . CUKUROVA MEDICAL JOURNAL, 2020, 45, 266-271. 45 + 0
    International - ESCI kapsamındaki dergilerde yayımlanan tam makale 300
    2023
    2. DOGAN, H.; OZCIMEN, A.; SILICI, S. Effects of olive oil-based propolis, caffeic acid phenethyl ester, and methylprednisolone on differentiation of human acute myeloid leukemia cells.. JOURNAL OF RESEARCH IN PHARMACY, 2023, 27, 677-686. 300 + 0
    https://www.jrespharm.com/

    Publications_004.pdf

    2021
    1. ERSOY, L. Evaluation of Cytokine Signal Suppressor Gene Polymorphisms in Turkish Patients with Active Tuberculosis. TURKISH JOURNAL OF IMMUNOLOGY, 2021, 9, 114-119. 0 + 0
    http://dx.doi.org/10.4274/tji.galenos.2021.09709

    Publications_003.pdf

    International - publications.sections.8 180
    2023
    2. DOĞAN, H.; ÖZÇİMEN, A.; SİLİCİ, S. . JOURNAL OF RESEARCH IN PHARMACY (ONLINE), 2023, 27, 677-686. 100 + 0
    10.29228/jrp.350

    2021
    1. ERSOY, L.; ÖZÇİMEN, A.; ÜLGER, M.; ÇALIKOĞLU, M.; ASLAN, G. . TURKISH JOURNAL OF IMMUNOLOGY, 2021, 9, -119. 80 + 0
    10.4274/tji.galenos.2021.09709

    National - Covered by ULAKBIM 780
    2011
    4. ŞAHAN FIRAT, S.; ÖZÇİMEN, A. Gene Therapy and Application Areas (review). MERSIN UNIVERSITY MEDICAL JOURNAL, 2011, 12, 1-7. 200 + 0
    2008
    3. ÖZÇİMEN, A.; ÇETİN, M. Methylprednisolone induce terminal differentiation in the U-937 human monocytic leukemia cells. TURKISH JOURNAL OF IMMUNOLOGY, 2008, 13, 10-14. 200 + 5
    2007
    2. EVEREST, Z.; ÖZÇİMEN, A. An ethnobotanical studies on the assessment of Anamur Yayla plants in cancer therapies. MERSIN UNIVERSITY MEDICAL JOURNAL, 2007, 8, 19-27. 200 + 0
    2006
    1. ÖZÇİMEN, A.; KART, A.; OKUR, H.; TUNCER, A.; ÇETİN, M. The differentiation effect of 6α-methylprednisolone on HL-60 cells”. . MERSIN UNIVERSITY MEDICAL JOURNAL, 2006, 7, 32-36. 180 + 0
    National - Other 100
    2008
    1. ÖZÇİMEN, A.; ÇETİN, M. . TURKISH JOURNAL OF IMMUNOLOGY, 2008, 13, 10-14. 100 + 0

    National - Scientific Book (Excluded Thesis) 0
    1. ALABAŞ, E.; ÖZÇİMEN, A. Sağlık ve Bilim 2023: Kök Hücre ve Rejeneratif Tıp I, ISBN: 978-625-6504-97-4, Efe Akademi, Number of print: 1, Total Printing Number: , 17 Page, Turkish, İSTANBUL, Turkey, 2023. 0
    2. DOĞAN, H.; ÖZÇİMEN, A. Sağlık ve Bilim 2023: Kök Hücre ve Rejeneratif Tıp I, ISBN: 978-625-6504-97-4, Efe Akademi, Number of print: 1, Total Printing Number: , 13 Page, Turkish, İSTANBUL, Turkey, 2023. 0
    3. KIRBIYIK, I.; ÖZÇİMEN, A. Sağlık ve Bilim: Kök Hücre ve Rejeneratif Tıp I, ISBN: 978-625-6504-97-4, Efe Akademi, Number of print: 1, Total Printing Number: , 11 Page, Turkish, İSTANBUL, Turkey, 2023. 0
    4. ALABAŞ, E.; ÖZÇİMEN, A. Sağlık ve Bilim 2023: Genel Embriyoloji II, ISBN: 978-625-6600-14-0, Efe Akademi, Number of print: 1, Total Printing Number: , 12 Page, Turkish, İSTANBUL, Turkey, 2023. 0
    5. DOĞAN, H.; ÖZÇİMEN, A. Sağlık ve Bilim 2023: Genel Embriyoloji II, ISBN: 978-625-6600-14-0, Efe Akademi, Number of print: 1, Total Printing Number: , 16 Page, Turkish, İSTANBUL, Turkey, 2023. 0

    International - SCI/SCI-Exp. indexed - Poster 600

    4. ÇITAK, C.; ALAKAYA, M.; KAYA, S.; YILMAZ, S.; KÜLEKÇİ, G.; ÖZÇİMEN, A., The effects of using glutamine and hydroxymethyl butyrate on the gastrointestinal mucositis due to the use of methotrexate in rats. Pediatric Blood and Cancer Meeting, 2014-10-22, 2014-10-25, TORONTO, Canada, 2014. 100

    3. ATA, A.; ÖZÇİMEN, A.; KURT, H.; TİFTİK, N.; ARICAN, A.; BÜYÜKAFŞAR, K., Augmentation of the cytotoxicty of Ibondranate by Y-27632 in prostate cancer cell lines. 37th ESMO (European Society of Medical Oncology) Congress, 2012-09-28, 2012-10-02, VIENNA, Austria, 2012. 187

    2. YÜCEL, A.; DİLEK, K.; SABA, D.; ÖZÇİMEN, A.; SARICAOĞLU, H.; YURTKURAN, M.; ORAL, H., Interleukin-2 gene polymorphism in Turkish patients with Behcet’s disease and its association with ocular involvement. European Congress of Immunology, 2012-09-05, 2012-09-08, GLASGOW, England / United Kingdom, 2012. 125

    1. ATA, A.; ÖZÇİMEN, A.; KURT, H.; TİFTİK, N.; ARICAN, A.; BÜYÜKAFŞAR, K., Augmentation of the cytotoxicity of ibondranate by y-27632, a rho kinase inhibitor, in prostate cancer cells. 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), 2012-06-01, 2012-06-06, CHICAGO, United States of America, 2012. 187

    International - Abstract - Oral 2960

    32. Özcan, T.; DOĞAN, H.; ÖZÇİMEN, A., PROLIFERATIVE AND CYTOXIC EFFECTS OF AURORA KINASE B INHIBITOR TOZASERTİB AND VITAMIN-D3 ON ACUTE MYELOID LEUKEMIA (AML) CELL. CUKUROVA 12th INTERNATIONAL SCIENTIFIC RESEARCHES CONFERENCE March 9-12, 2024/ Adana, TÜRKİYE, 2024-03-09, , ADANA, Turkey, 2024. 100
    Scientific_Meetings_018.pdf

    31. İnanç, H.; TAVŞANOĞLU, Y.; DOĞAN, H.; Tarancı, Ö.; KAÇAR, Y.; ÜNAL, S.; ÖZÇİMEN, A., ANALYSIS OF CYTOKINE SIGNAL SUPPRESSOR-3 (SOCS-3) GENE POLYMORPHISM IN PATIENTS WITH SICKLE CELL ANEMIA. CUKUROVA 12th INTERNATIONAL SCIENTIFIC RESEARCHES CONFERENCE March 9-12, 2024/ Adana, TÜRKİYE, 2024-03-09, , ADANA, Turkey, 2024. 20
    Scientific_Meetings_019.pdf

    30. DOĞAN, H.; ÖZÇİMEN, A.; SİLİCİ, S., İNSAN AKUT MİYELOİD LÖSEMİ TEDAVİSİNDE KULLANILAN METİLPREDNİZOLON İLE KAFEİK ASİT FENETİL ESTERİN (CAPE) ETKİLEŞİMİ. 7. ULUSLARARSI MULTİDİSİPLİNER İYİ TIBBİ ARAŞTIRMALAR KONGRESİ, 2020-10-24, 2020-10-31, MERSİN, Turkey, 2020. 100
    Scientific_Meetings_015.pdf

    29. ÇOLAK, C.; ALABAŞ, E.; KIRBIYIK, İ.; ÖZÇİMEN , A., PAN-AURORA KİNAZ İNHİBİTÖRÜ DANUSERTIB'İN PANKREATİK KARSİNOMA HÜCRELERİNDE KROMOSOMAL GEÇİŞ KOMPLEKS GENLERİNİN MRNA İFADE DÜZEYLERİ ÜZERİNE ETKİLERİNİN İNCELENMESİ. 7. ULUSLARARSI MULTİDİSİPLİNER İYİ TIBBİ ARAŞTIRMALAR KONGRESİ, 2020-10-24, 2020-10-31, MERSİN, Turkey, 2020. 65
    Scientific_Meetings_016.pdf

    28. DOĞAN, H.; ÖZÇİMEN, A.; SİLİCİ, S., LÖSEMİ TEDAVİSİNDE KULLANILAN KAFEİK ASİT FENETİL ESTER (CAPE) VE METİLPREDNİZOLONUN HL-60 HÜCRELERİNDE DİFERANSİYEASYON ÜZERİNE ETKİSİNİN BELİRLENMESİ. 7. ULUSLARARSI MULTİDİSİPLİNER İYİ TIBBİ ARAŞTIRMALAR KONGRESİ, 2020-10-24, 2020-10-31, MERSİN, Turkey, 2020. 100
    Scientific_Meetings_012.pdf

    27. DOĞAN, H.; ÖZÇİMEN, A.; SİLİCİ, S., LÖSEMİ TEDAVİSİNDE KULLANILAN KAFEİK ASİT FENETİL ESTER (CAPE) VE METİLPREDNİZOLONUN HL-60 HÜCRELERİNDE FARKLILAŞMA ÜZERİNE ETKİSİNİN BELİRLENMESİ. 7. ULUSLARARSI MULTİDİSİPLİNER İYİ TIBBİ ARAŞTIRMALAR KONGRESİ, 2020-10-24, 2020-10-31, MERSİN, Turkey, 2020. 100
    Scientific_Meetings_017.pdf

    26. DOĞAN, H.; ÖZÇİMEN, A.; SİLİCİ, S., İNSAN AKUT MİYELOİD LÖsemi HÜCRELERİNDE KAFEİK ASİT FENETİL ESTER'İN (CAPE) HÜCRE DÖNGÜSÜ ÜZERİNE ETKİSİ. 7. ULUSLARARSI MULTİDİSİPLİNER İYİ TIBBİ ARAŞTIRMALAR KONGRESİ, 2020-10-24, 2020-10-31, MERSİN, Turkey, 2020. 100
    Scientific_Meetings_014.pdf

    25. ÇAĞLAR, M.; DOĞAN, H.; ALABAŞ, E.; KIRBIYIK, A.; ÖZÇİMEN, A., AURORA KİNAZ B İNHİBİTÖRÜ TOZASERTİB VE METHYLPREDNISOLONE'NİN LÖKEMİ HÜCRELERDE CPC (KROMOZOMAL YOLCU KOMPLEKSİ) YOLU ÜZERİNE ETKİLERİ. 7. ULUSLARARSI MULTİDİSİPLİNER İYİ TIBBİ ARAŞTIRMALAR KONGRESİ, 2020-10-24, 2020-10-31, MERSİN, Turkey, 2020. 50
    Scientific_Meetings_013.pdf

    24. ERSOY, L.; ÖZÇİMEN, A.; ÜLGER, M.; ÇALIKOĞLU, M.; ASLAN, G., Tüberküloz Hastalarında SOCS-1 Gen Polimorfizmlerinin Araştırılması. Uluslararası Mikobakteri Sempozyumu, 2019-11-28, 2019-11-30, Mersin, Turkey, . 80

    23. Alabaş, E.; Özçimen, A., İNSAN PANKREATİK KANSER HÜCRELERİNDE DAPI-A YÖNTEMİ İLE OTOFAJİK HÜCRELERİN BELİRLENMESİ. I. ULUSLARARASI AKDENİZ SEMPOZYUMU, 2018-11-01, 2018-11-03, MERSİN, Turkey, 2018. 100
    Scientific_Meetings_002.pdf

    22. ALABAŞ, E.; Özçimen, A., CFPAC-1 PANKREAS ADENOKARSİNOMA HÜCRELERİNDE YARA AÇMA DENEYİ İLE MİGRASYON ANALİZİ. I. Uluslararası Mersin Sempozyumu, 2018-11-01, 2018-11-03, MERSİN, Turkey, 2018. 100
    http://mersinsempozyumu.mersin.edu.tr

    21. Ozcimen, A.; Kırbıyık, İ., PAN AURORA KINAZ İNHIBITÖRÜ DANUSERTIB'IN CFPAC-1 PANKREAS HÜCRELERINDE HÜCRE DÖNGÜSÜ ÜZERINE ETKISININ ARAŞTIRILMASI. I. Uluslararası Akdeniz Sempozyumu, 2018-11-01, 2018-11-03, MERSİN, Turkey, 2018. 100
    http://akdenizsempozyumu.mersin.edu.tr

    20. ALABAŞ, E.; Özçimen, A., PAN-AURORA KİNAZ İNHİBİTÖRÜ OLAN DANUSERTİB’İN PANKREAS KANSERİ HÜCRELERİNDE OTOFAJİ ÜZERİNE ETKİLERİNİN ARAŞTIRILMASI. I. Uluslararası Mersin Sempozyumu, 2018-11-01, 2018-11-03, MERSİN, Turkey, 2018. 100
    http://mersinsempozyumu.mersin.edu.tr

    19. ALABAŞ, E.; Özçimen, A., MIA PaCa-2 İNSAN PANKREATİK KARSİNOMA HÜCRELERİNDE YARA AÇMA DENEYİ İLE MİGRASYON ANALİZİ. I. Uluslararası Akdeniz Sempozyumu, 2018-11-01, 2018-11-03, MERSİN, Turkey, 2018. 100
    http://akdenizsempozyumu.mersin.edu.tr

    18. KIRBIYIK, i.; Özçimen, A., PAN AURORA KINAZ İNHIBITÖRÜ DANUSERTIB'IN CFPAC-1 PANKREAS HÜCRELERİNDE SİTOTOKSİSİTE ÜZERINE ETKİSİ. I. Uluslararası Akdeniz Sempozyumu, 2018-11-01, 2018-11-03, MERSİN, Turkey, 2018. 100
    http://akdenizsempozyumu.mersin.edu.tr

    17. Ozcimen, A.; Alabaş, E., DANUSERTIB UYGULANAN MIA PaCa-2 İNSAN PANKREATİK KANSER HÜCRELERİNİN CIM-PLATE 16 KULLANILARAK MİGRASYON ANALİZİ. I. Uluslararası Akdeniz Sempozyumu, 2018-11-01, 2018-11-03, MERSİN, Turkey, 2018. 100
    http://akdenizsempozyumu.mersin.edu.tr

    16. KIRBIYIK, İ.; Özçimen, A., PAN AURORA KİNAZ İNHİBİTÖRÜ DANUSERTİB'İN CFPAC-1 PANKREAS HÜCRELERİNDE APOPTOZ ÜZERİNE ETKİSİ. I. Uluslararası Akdeniz Sempozyumu, 2018-11-01, 2018-11-03, MERSİN, Turkey, 2018. 100
    http://akdenizsempozyumu.mersin.edu.tr

    15. KIRBIYIK, İ.; Özçimen, A., PAN AURORA KİNAZ İNHİBİTÖRÜ DANUSERTİB'İN MİA PACA-2 PANKREAS HÜCRELERİNDE APOPTOZ ÜZERİNE ETKİSİ. I. Uluslararası Mersin Sempozyumu, 2018-11-01, 2018-11-03, MERSİN, Turkey, 2018. 100
    http://mersinsempozyumu.mersin.edu.tr

    14. ALABAŞ, E.; Özçimen, A., PAN-AURORA KİNAZ İNHİBİTÖRÜ DANUSERTIB İLE CFPAC-1 PANKREATİK KANSER HÜCRELERİNDE MİGRASYON ANALİZİ. I. Uluslararası Mersin Sempozyumu, 2018-11-01, 2018-11-03, MERSİN, Turkey, 2018. 100
    http://mersinsempozyumu.mersin.edu.tr

    13. ÖZÇİMEN, A.; ÖZTÜRK, E., Apoptotic Effect of Arum dioscoridis with Tozasertib in CFPAC-1 Pancreas Carcinoma Cell Line. INTERNATIONAL ADVENCED RESEARCEH AND ENGİNEERİNG CONGRESS, 2017-11-16, 2017-11-18, OSMANİYE, Turkey, . 100

    12. ÖZTÜRK, E.; ÖZÇİMEN, A., ARUM DIOSCORIDIS BİTKİ EKSTRAKTININ TOZASERTIB İLE BİRLİKTE CFPAC-1 PANKREAS KARSİNOMA HÜCRE HATTINDA ANTİ-METASTATİK ETKİSİ. INTERNATIONAL ADVENCED RESEARCHES AND ENGINEERING CONGRESS, 2017-11-16, 2017-11-18, OSMANİYE, Turkey, . 100

    11. ÇELİK, H.; ÖZÇİMEN, A.; ÖZTÜRK, E., The Effect of Tozasertib on the Chromosomal Passanger Complex Gene Expressions in the CFPAC-1 Pancreas Carcinoma Cell Line. INTERNATIONAL ADVENCED RESEARCHES AND ENGINEERING CONGRESS, 2017-11-16, 2017-11-18, , , . 100

    10. ÖZTÜRK, E.; ÖZÇİMEN, A.; ÇELİK, H., The Synergistic Effect of Arum dioscoridis Extracts And Tozasertib on the Chromosomal Passenger Complex Gene Expressions in the CFPAC-1 Pancreas Carcinoma Cell Line. INTERNATIONAL ADVANCED RESEARCHES AND ENGINEERING CONGRESS, 2017-11-16, 2017-11-18, OSMANİYE, Turkey, . 100

    9. TARANCI, Ö.; KAÇAR, Y.; ÖZÇİMEN, A.; ÜNAL, S.; TEZOL, Ö., ORAK HÜCRE HASTALARINDA HbF DÜZEYİNİ ETKİLEYEN HMIP-2 LOKUSU rs9399137, rs9402685 ve rs11759553 POLİMORFİZMLERİNİN ARAŞTIRILMASI. ULUSLARARASI UYGULAMALI BİLİMLER VE MÜHENDİSLİK KONGRESİ, 2017-11-16, 2017-11-18, Osmaniye, Turkey, 2017. 70
    http://iarec.osmaniye.edu.tr

    8. ÖZTÜRK, E.; ÖZÇİMEN, A.; ÇELİK, H., ARUM DIOSCORIDIS BİTKİ EKSTRAKTININ TOZASERTIB İLE BİRLİKTE CFPAC-1 PANKREAS KARSİNOMA HÜCRE HATTINDA KROMOZOMAL GEÇİŞ KOMPLEKSİ GEN İFADELERİ ÜZERİNDEKİ ETKİSİ. ULUSLARARASI UYGULAMALI BİLİMLER VE MÜHENDİSLİK KONGRESİ, 2017-11-16, 2017-11-18, Osmaniye, Turkey, 2017. 100
    http://iarec.osmaniye.edu.tr

    7. ÇELİK, H.; ÖZÇİMEN, A.; ÖZTÜRK, E., AURORA KİNAZ – B İNHİBİTÖRÜ TOZASERTIB’İN CFPAC-1 PANKREAS DUKTAL ADENO KARSİNOMA HÜCRE HATTINDA KROMOZOMAL GEÇİŞ KOMPLEKSİ GEN İFADELERİ ÜZERİNDEKİ ETKİSİ. ULUSLARARASI UYGULAMALI BİLİMLER VE MÜHENDİSLİK KONGRESİ, 2017-11-16, 2017-11-18, Osmaniye, Turkey, 2017. 100
    http://iarec.osmaniye.edu.tr

    6. ÖZTÜRK, E.; ÖZÇİMEN, A., ARUM DIOSCORIDIS BİTKİ EKSTRAKTININ TOZASERTIB İLE BİRLİKTE CFPAC-1 PANKREAS KARSİNOMA HÜCRE HATTINDA ANTİ-METASTATİK ETKİSİ. ULUSLARARASI UYGULAMALI BİLİMLER VE MÜHENDİSLİK KONGRESİ, 2017-11-16, 2017-11-18, Osmaniye, Turkey, 2017. 100
    http://iarec.osmaniye.edu.tr

    5. ÖZÇİMEN, A.; ÖZTÜRK, E., ARUM DIOSCORIDIS BİTKİ EKSTRAKTININ TOZASERTIB İLE BİRLİKTE CFPAC-1 PANKREAS KARSİNOMA HÜCRE HATTINDA APOPTOTIK ETKİSİ. ULUSLARARASI UYGULAMALI BİLİMLER VE MÜHENDİSLİK KONGRESİ, 2017-11-16, 2017-11-18, Osmaniye, Turkey, 2017. 100
    http://iarec.osmaniye.edu.tr

    4. Öztürk, E.; ÖZÇİMEN, A.; YETKİN, D., The Cytotoxic and Apoptotic Effects of Arum dioscoridis Extract and Tozasertib Combination onto the CFPAC-1 Pancreatic Adenocarcinoma Cell Line. at the 1st INTERNATIONAL CONGRESS onMEDICINAL and AROMATIC PLANTS -naturaland healthy life- to be held, 2017-05-10, 2017-05-12, , , . 100

    3. ÖZTÜRK, E.; ÖZÇİMEN, A.; YETKİN, D., The Cytotoxic and Apoptotic Effects of Arum dioscoridis Extract and Tozasertib Combination onto the CFPAC-1 Pancreatic Adenocarcinoma Cell Line. I. INTERNATIONAL CONGRESS on MEDICINAL and AROMATIC PLANTS: “NATURAL and HEALTHY LIFE”, 2017-05-09, 2017-05-12, KONYA, Turkey, . 100

    2. ÖZTÜRK, E.; YETKİN, D.; ÖZÇİMEN, A., Arum dioscoridis Bitki Ekstraktının, Tozasertib ile Birlikte CFPAC-1 Pankreas AdenoKarsinoma Hücre Hattı Üzerindeki Sitotoksik ve Apoptotik Etkileri. 1. ULUSLARARASI TIBBİ AROMATİK BİTKİLER KONGRESİ, 2017-05-09, 2017-05-12, KONYA, Turkey, 2017. 100
    http://www.tabkon.org

    1. DİLEK, K.; ÖZÇİMEN, A.; SARICAOĞLU, H.; SABA, D.; YURTKURAN, M.; ORAL, H., Cytokine gene polymorphisms in Behçet’s Disease and their association with clinical and laboratory findings. 2nd Mediterrannean Clinical Immunology Meeting, 2008-10-04, 2008-10-07, ANTALYA, Turkey, 2008. 75

    International - Abstract - Poster 237

    6. SEVGİ, H.; ÖZÇİMEN, A.; ÖZDEMİR, Ö.; AYMAK, F.; UMUT, G.; KAÇAR, Y.; ÜNAL, S., The investigation of suppressor of cytokine signaling (SOCS-1 and SOCS-3) gene expression in sickle cell anemia. Molecular Immunology and Immunogenetics Congress, 2012-04-27, 2012-04-29, ANTALYA, Turkey, 2012. 32

    5. BUDAK, F.; ÖZÇİMEN, A.; KUNT UZASLAN, E.; GÖRAL, G.; AKDİŞ, A.; ORAL, H., T-regulatory cells and expressions of SOCS-1 and SOCS-3 in Sarcoidosis and their association with responsiveness to treatment. 2nd Mediterrannean Clinical Immunology Meeting, 2008-10-04, 2008-10-07, ANTALYA, Turkey, 2008. 37

    4. ÖZÇİMEN, A.; OKUR, H.; TUNCER, M.; KART, A.; ÇETİN, M.; HİÇSÖNMEZ, G., The differentiation of effect of 6α-methylprednisolone on HL-60 cells. XXXth World Congress of the International Society of Hematology, 2005-09-28, 2005-10-02, İSTANBUL, Turkey, 2005. 42

    3. ÖZÇİMEN, A.; OKUR, H.; CANPINAR, H.; KÖSE, Ö.; TUNCER, M.; GÜÇ, D.; KART, A., The cytotoxic and apoptotic effect of 6α-methylprednisolone on HL-60 cells. XXXth World Congress of the International Society of Hematology, 2005-09-28, 2005-10-02, İSTANBUL, Turkey, 2005. 35

    2. EVEREST, A.; ÖZÇİMEN, A.; BALIKÇI, O.; UÇAR, A.; SEYHAN, L., The biodiversity research of Icel (a city of South Turkey) and Probable risks of radiation on the species of Akkuyu Nuclear Power Station which has been plant to establish. NATO Advenced Research Workshop, Contaminated Forests: Recent Developments in Risk Identification and Future Perspectives, 1998-06-24, 1998-06-28, KIEV, Ukraine, 1998. 40

    1. ÖZÇİMEN, A.; DARLING, D.; FARZANEH, F., Expression of the Secretuary Leukoproteases Inhibitory gene in range of cancer cell lines. Postgraduate Poster Day at King’s College School of Medicine and Dentistry in the University of London, 1997-10-16, 1997-10-16, LONDRA, England / United Kingdom, 1997. 50

    National - Full text - Oral 40

    1. KÖTOĞLU, R.; BİLGİN, B.; KOŞUMCU, F.; KAYAN, B.; ÖZÇİMEN, A.; GİZİR, A.; BÜYÜKAFŞAR, K., The cytotoxic and apoptotic effects of cranberries (Cornus mas) extract in myelomonocytic leukemia (U-937) cells. 2nd Traditional Foods Semposium , 2009-05-27, 2009-05-29, VAN, Turkey, 2009. 40

    National - Abstract - Oral 300

    7. Çelik, H.; Özçimen , A.; Kaçar , Y., Aurora-kinaz inhibitörü Tozasertib’inpankreas karsinoma hücrelerinde kaspaz aktivitesine etkisinin qPCR ile incelenmesi. 23. Ulusal Biyoloji Kongresi, 2016-09-05, 2016-09-09, Gaziantep, Turkey, 2016. 50
    http://www.ubk2016.com

    6. Kaplan , C.; Özçimen , A.; Büyükafşar, K.; Kaçar , Y., Rho-kinaz inhibitörü Fasudil’in pankreas karsinoma hücrelerinde sitotoksisite ve metastaz ilişkisinin Real-Time Hücre Analizörü ile araştırılması. 23. Ulusal Biyoloji Kongresi, 2016-09-05, 2016-09-09, Gaziantep, Turkey, 2016. 42
    http://www.ubk2016.com

    5. ATA, A.; ÖZÇİMEN, A.; KURT, A.; TİFTİK, R.; BÜYÜKAFŞAR, K.; ARICAN, A., Augmentation of the cytotoxicity of ibondranate by Y-27632, a Rho kinase inhibitor, in prostate cancer cell line. 4th Medical Oncology Congress, 2012-03-21, 2012-03-25, ANTALYA, Turkey, 2012. 37

    4. ÖZÇİMEN, A.; YURTSEVER, A.; BÜYÜKAFŞAR, K., The synergistic effect of Metilprednizolon and Vitamine-D3 onto the DR-nm23 gene expression and apoptosis in leukemic cells. XIth National Medical Biology and Genetics Congress, 2009-10-28, 2009-10-31, BODRUM, Turkey, 2009. 50

    3. ÜNAL, S.; CANACANKATAN, N.; ANTMEN, E.; ÖZÇİMEN, A., The investigation TNFSF15 gene expression in patients with Sickle Cell Anemia. 7th National Pediatrics Hematology Congrees, 2009-05-24, 2009-05-27, ANKARA, Turkey, 2009. 32

    2. ÖZÇİMEN, A.; LAWRY, J., The effects of novel o-crezol and quinoline compounds onto the cytotoxicity by using Neutral Red Dye Uptake (NRUT) and Trypan Blue (TBE) tests and onto the DNA-cell cycle in MRC-5 and A549 cells. IInd Multidisipliner Canser Semposium, 2008-02-24, 2008-02-28, BURSA, Turkey, 2008. 50

    1. ÖZÇİMEN, A.; HATIRNAZ, Ö.; SAVLI, H.; KOCAEFE, Ç.; ÇETİN, M.; TUNCER, M.; KART, A., The effects of methyleprednisolone on DR-nm23 gene expression in HL-60 cells. 9th National Medical Biology Congress, 2005-11-24, 2005-11-27, MANİSA, Turkey, 2005. 37

    National - Abstract - Poster 310

    15. Yılmaz , T.; Kaçar, Y.; Özçimen, A., Pankreas karsinoma (BxPC-3) hücre hattında Doxorubicin’insitotoksik ve apoptotik etkileri. 23. Ulusal Biyoloji Kongresi, 2016-09-05, 2016-09-09, Gaziantep, Turkey, 2016. 25
    http://www.ubk2016.com

    14. Çelik, H.; Özçimen , A.; Kaçar, Y., Pankreatik duktal adenokarsinom CFPAC-1 hücrelerinde IC50 Konsantrasyon/Zaman ayarlı Tozasertib’in DNA hücre döngüsüne etkisinin akan hücre ölçer ile belirlenmesi . 23. Ulusal Biyoloji Kongresi, 2016-09-05, 2016-09-09, Gaziantep, Turkey, 2016. 25
    http://www.ubk2016.com

    13. Kaplan, C.; Özçimen, A.; Büyükafşar, K.; Kaçar, Y., Rho-kinaz inhibitörü Fasudil’in pankreas karsinoma hücrelerinde apoptoz ilişkisinin Real-Time PCR ve akım sitometrik olarak incelenmesi. 23. Ulusal Biyoloji Kongresi, 2016-09-05, 2016-09-09, Gaziantep, Turkey, 2016. 21
    http://www.ubk2016.com

    12. Çelik, H.; Özçimen, A.; Öztürk, E.; Kaçar, Y., Tozasertib’in IC50 konsantrasyonunda pankreatik adenokarsinoma hücre hattında apoptotik aktivitesi”. 7. DETAE Günleri, 2015-11-11, 2015-11-12, İstanbul, Turkey, 2015. 21
    http://www.detaegunleri.org

    11. AY, G.; KAÇAR, Y.; ÜNAL, S.; ÖZÇİMEN, A.; YILMAZ, T.; BAŞUT, N., Orak hücre hastası çocuklarda PONL55M ve PONQ192R polimorfizmleri analizi. I. Hematolojik Genetik Sempozyumu, 2013-12-02, 2013-12-04, İZMİR, Turkey, 2013. 13

    10. REYHANİ, B.; AYMAK, F.; UMUT, G.; KAÇAR, Y.; BÜYÜKAFŞAR, K.; ORAL, H.; ÖZÇİMEN, A., The investigation of gene expressions of Supressor of the Cytokine Signalling in methylprednisolone and vitamin-D3 treatment chronic myeloblastic leukemia (K-562) cells. XIIth National Medical Biology and Genetics Congress, 2011-10-27, 2011-10-30, ANTALYA, Turkey, 2011. 5

    9. AKBAŞ, E.; ERAS ERDOĞAN, N.; ARSLAN MAMUR, B.; TÜRKMENOĞLU, Ö.; SUNGUR, M.; ÖZÇİMEN, A., No Association between Interleukin-1B C-31T Polymorphism and Breast Cancer. 9th National Medical Genetics Congress of Turkish Medical Genetics Society with Internal Participation, 2010-12-01, 2010-12-05, İSTANBUL, Turkey, 2010. 10

    8. ÖZÇİMEN, A.; YURTSEVER, A.; BÜYÜKAFŞAR, K.; KART, A.; ÇETİN, M.; HİÇSÖNMEZ, G., DR-nm23 gene expression by Real-Time PCR technique was shown in two myelodysplastic patients administered with high dose methylprednisolone. XIth National Medical Biology and Genetics Congress, 2009-10-28, 2009-10-31, BODRUM, Turkey, 2009. 21

    7. ÖZÇİMEN, A.; LAWRY, J.; POTTER, C., The cytotoxicity and DNA cell cycle analysis of novel five types of acridine compounds in A549 lung carcinoma cells. XIth National Medical Biology and Genetics Congress, 2009-10-28, 2009-10-31, BODRUM, Turkey, 2009. 25

    6. BUDAK, F.; ÖZÇİMEN, A.; KUNT UZASLAN, E.; SÖZER, S.; GÖRAL, G.; AKDİŞ, A.; ORAL, H., Increased suppressor of cytokine signalling (SOCS) -1 and -3 expressions and regulatuary T cells in patients with responding to treatment sarcoidosis. XIXth. National Immunology Congress, 2007-11-21, 2007-11-24, ANTALYA, Turkey, 2007. 17

    5. ÖZÇİMEN, A.; LAWRY, J., The flow cytometric investigation of two novel compounds onto the protein expression in MRC-5 (fetal lung fibroblast) and A549 (small cell lung carcinoma) cells. Xth National Medical Biology and Gentics Congress, 2007-09-06, 2007-09-09, ANTALYA, Turkey, 2007. 25

    4. ÖZÇİMEN, A.; LAWRY, J., The investigation of the effects of seven-novel compounds on cytotoxicity and cell cycle in A375 (malignant melanoma cell line) cells. Xth National Medical Biology and Gentics Congress, 2007-09-06, 2007-09-09, ANTALYA, Turkey, 2007. 25

    3. ÖZÇİMEN, A.; ÇETİN, M., The terminal differentiation effect of methylprednisolone in myelomonocytic leukemia (U937) cells. Xth National Medical Biology and Gentics Congress, 2007-09-06, 2007-09-09, ANTALYA, Turkey, 2007. 25

    2. EVEREST, A.; ÖZÇİMEN, A., Medicinal plants in Cancer Research. Vth Lokman physicians Medical History and Folkloric Medicine Days, 2007-05-24, 2007-05-26, DENİZLİ, Turkey, 2007. 25

    1. ÖZÇİMEN, A.; LAWRY, J., The effects of novel acridine compounds on cytotoxicity and cell cycle in MCF-7 cells. Istanbul Breast Cancer Conferance, 2006-09-14, 2006-09-16, İSTANBUL, Turkey, 2006. 25

    National - Manager 2700

    28. , BAP, Project Number: , 21000 TL, Manager, Continue... 100

    27. Antimetastatic Effect Of The Vitexin On ZEB1 + (CFPAC-1) And ZEB1 - (MIAPaCa-2) Pancreatic Cancer Cells , BAP, Project Number: 2022-2-TP2-4735, 15000 TL, Manager, Continue... 100

    26. , BAP, Project Number: , 18000 TL, Manager, Continue... 100

    25. , BAP, Project Number: , 9078 TL, Manager, Continue... 100

    24. Investigation of the Effects of Turkish Propolis and Methylprednisolone on Human Acute Myeloid Leukemia (HL-60) Cell, BAP, Project Number: 2018-1-TP3-2826, 21000 TL, Manager, Continue... 100

    23. The Investigation of the Synergistic Effects of A Pan-Aurora Kinase Inhibitor Danusertib and Caffeic Acid Phenyl Ester (CAPE) on Pancreatic Cancer Cells, BAP, Project Number: 2021-1-TP3-4352, 25000 TL, Manager, Continue... 100

    22. Investigation of SOCS-1 Gene Polymorphisms in Tuberculosis Patients, BAP, Project Number: 2018-1-TP2-2827, 10992 TL, Manager, Continue... 100

    21. The Investigation of the Effects of Pan-Aurora Kinase Inhibitor Danusertib onto the Levels of mRNA Expression of Chromosomal Passenger Complex Gene in Pancreatic Carcinoma Cells, BAP, Project Number: 2019-1-TP2-3444, 13000 TL, Manager, Continue... 100

    20. The investigation of the Anticancer Effects of Pan-Aurora Kinase İnhibitor Danusertib and Apigenin 8-C Glucoside (Vitexin) in Breast Cancer Epithelial Cells, BAP, Project Number: 2019-2-TP3-3609, 18000 TL, Manager, Continue... 100

    19. Effects of Limonin and Nomilin, Citrus Alkaloids, on Proliferation and Differentiation on Preadipocytes (3T3-L1), BAP, Project Number: 2021-1-TP2-4239, 11670 TL, Manager, Continue... 100

    18. , BAP, Project Number: , 7000 TL, Manager, 2020,Completed. 100

    17. , BAP, Project Number: , 10992 TL, Manager, 2020,Completed. 100

    16. , BAP, Project Number: , 16250 TL, Manager, 2019,Completed. 100

    15. , projects.kurumlar.21, Project Number: , 29953 TL, Manager, 2019,Completed. 0

    14. , BAP, Project Number: , 18750 TL, Manager, 2019,Completed. 100

    13. , BAP, Project Number: , 11000 TL, Manager, 2018,Completed. 100

    12. Investigation of SOCS-1 Gene Polymorphism from Cytokine Signal Suppressors (SOCS Protein Family) in Sickle Cell Disease, BAP, Project Number: 2017-2-AP2-2538, 15000 TL, Manager, 2018,Completed. 100

    11. The investigation of Tozasertib, An Aurora Kinase Inhibitor, and Vitamin-D3 on to the CPC (Chromosomal Passanger Complex) Pathway in Leukemic Cells, BAP, Project Number: 2016-1-TP2-1415, 11000 TL, Manager, 2018,Completed. 100

    10. , BAP, Project Number: , 10995 TL, Manager, 2018,Completed. 100

    9. THE INVESTIGATION OF THE EFFECT OF DANUSERTIB, A PAN-AURORA KINASE INHIBITOR, ONTO AUTOPHAGY, METASTASİS AND EPİTHELİAL MESENCHYMAL TRANSİTİON (EMT) IN PANCREATIC CANCER CELLS, BAP, Project Number: 2017-1-TP2-2254, 10995 EUR, Manager, 2018,Completed. 100

    8. THE INVESTIGATION OF THE EFFECT OF DANUSERTIB, A PAN-AURORA KINASE INHIBITOR, ONTO CYTOTOXICITY, CELL CYCLE AND APOPTOSIS IN PANCREATIC CANCER CELLS , BAP, Project Number: 2017-1-TP2-2252, 10996 EUR, Manager, 2018,Completed. 100

    7. In Vitro Investigation of Anticancer Effects of Arum dioscoridis Plant Extracts with the Tozasertib onto the CFPAC-1 Pancreatic Carcinoma Cell Line, BAP, Project Number: 2016-1-TP3-1414, 20900 TL, Manager, 2017,Completed. 100

    6. Aurora Kinaz B İnhibitörü Tozasertib ve Metilprednizolon birlikteliğinin lösemik hücrelerde CPC (Chromosomal Passanger Complex) Yolağı Üzerindeki Etkilerinin Araştırılması, BAP, Project Number: 2015-TP2-1177, 7000 TL, Manager, 2017,Completed. 100

    5. The investigation of the effect of tozasertibe, a Aurora Kinase-B inhibitor, onto the Chromosomal Passanger Complex (CPC) pathway in Pancreatic Carcinoma Cells., BAP, Project Number: MEÜ BAP-FBE BB(HÇ) 2014-1YL, 10000 TL, Manager, 2015,Completed. 100

    4. The investigation of effect of Fasudil (HA-1077), a Rho kinase inhibitor, onto the relation of cytotoxicity, apoptosis and metastasis in pankreatic carcinoma cells (BxPC-3), BAP, Project Number: MEÜ-BAP-FBE BB (CK) 2012-4 YL, 10000 TL, Manager, 2015,Completed. 100

    3. The investigation of suppressor of cytokine signaling (SOCS-1 and SOCS-3) gene expression in patients with sickle cell anemia, BAP, Project Number: MEÜ-BAP-FBE B(HS) 2011-3 YL, 10000 TL, Manager, 2012,Completed. 100

    2. The investigation of gene expressions of Supressor of the Cytokine Signalling in methylprednisolone and vitamin-D3 treatment chronic myeloblastic leukemia (K-562) cells, BAP, Project Number: MEÜ-BAP BB(BM) 2009-7 YL , 7000 TL, Manager, 2011,Completed. 100

    1. The synergistic effect of Metilprednizolon and Vitamine-D3 onto the DR-nm23 gene expression, apoptosis and differentiation in leukemic cells, BAP, Project Number: ”. MEÜ-BAP FEF(AAÖ) 2007-1, 10000 TL, Manager, 2008,Completed. 100

    National - Researcher 850

    18. Evaluation of the Relationship Between Complications of Mouth-Tooth and Jaw Bone and Endodontic Condition with Hematological Findings and Systemic Inflammation in Children with Sickle Cell Disease, BAP, Project Number: 2019-3-AP5-3803, 47450 TL, Researcher, Continue... 50

    17. Improvement of Research Laboratory Infrastructure for Biological Sciences, BAP, Project Number: 2024-AP5-5008, 1311600 TL, Researcher, Continue... 50

    16. Histological and genetic evaluation of the cytotoxic and apoptotic effects of Caffeic acid phenethyl ester (CAPE) on the acute myeloid leukemia cell line HL-60, BAP, Project Number: 2021-1-AP3-4372, 25000 TL, Researcher, Continue... 50

    15. , BAP, Project Number: , 47450 TL, Researcher, Continue... 50

    14. Determining the Efficacy of Different Types and Subtypes of Immune System Cells as Personalized Cancer Immunotherapy Agents by Utilizing from In Vitro and Ex Vivo Methods, BAP, Project Number: 2021-1-AP5-4286, 430000 TL, Researcher, Continue... 50

    13. , BAP, Project Number: , 54000 TL, Researcher, 2018,Completed. 50

    12. , BAP, Project Number: , 30000 TL, Researcher, 2017,Completed. 50

    11. The research of HMIP-2(rs9399137-rs9402685-rs11759553) locus of polymorphism which affects the level of HbF insickle cell patients, BAP, Project Number: 2016-1-TP2-1410, 11000 TL, Researcher, 2017,Completed. 50

    10. The investigation of Doxorubicin’s anti-cancer effects on pancreas carcionoma (BxPC-3) cell line, BAP, Project Number: MEÜ BAP-FBE BB(TY) 2013-4 YL, 10000 TL, Researcher, 2014,Completed. 50

    9. The role of IGF-1 and IGFBP-3 in the pathogenesis of inflammation in sickle cell disease, BAP, Project Number: MEÜ BAP-TF DTB (NB) 2012-8TU, 20000 TL, Researcher, 2012,Completed. 50

    8. The analysis of Paraoxonase 1 (PON 1) gene polymorphisms in the patients with Sickle Cell Disease, BAP, Project Number: MEÜ BAP FBE BB(GA) 2012-8 YL, 10000 TL, Researcher, 2012,Completed. 50

    7. The effect of glutamine and hydroxymetyl butyrate onto the gastrointestinal mucozide depending on metotrexate using in rats, BAP, Project Number: MEÜ BAP-TF DTB (MA) 2012-4 TU, 20000 TL, Researcher, 2012,Completed. 50

    6. The investigation of gene expression and serum level of Fractalkine, a memmber of chemokine family, in the patients with sickle cell anemia, BAP, Project Number: MEÜ BAP-TF DTB (ÖÖÇ) 2011-5 TU , 20000 TL, Researcher, 2012,Completed. 50

    5. The investigation of TNFSF15 gene expression in patients with ITP and Sickle Cell Anemia, TÜBİTAK, Project Number: TÜBİTAK-SBAG-HD-255(107S308), 20000 TL, Researcher, 2009,Completed. 50

    4. The determination of DR-nm23 gene expression level in Acute Myeloid Leukemia patients treatment with high dose methylprednisolone (HDMP), HUBAP, Project Number: HÜ-BAP 01 02 101 022, 28000 TL, Researcher, 2008,Completed. 0

    3. The effects of Rho-kinase and cyclooxigenase inhibitors with cyclophosphamide combinations onto the range of tumor cell lines, BAP, Project Number: MEÜ-BAP SBE TTB (ED) 2006-1 DR, 5000 TL, Researcher, 2007,Completed. 50

    2. The investigation of the effect of Acetylsalicilic acide (aspirine) and Rho-kinase Y-27632 combinations onto the human neuroblastoma and leukemia cell line, BAP, Project Number: MEÜ-BAP TF TTB (NAA) 2006-1, 40000 TL, Researcher, 2007,Completed. 50

    1. The effect of steroid on DR-nm23 gene expression, apoptosis and differentiation in human acute myeloid leukemia (HL-60) cell line, TÜBİTAK, Project Number: TÜBİTAK SBAG- 2515 (101S215), 10000 TL, Researcher, 2005,Completed. 50

    Supervised Master Theses 2400

    12. HALE EZGİ İNANÇ, Investigation of SOCS-3 Gene Polymorphism from Cytokine Signal Suppressors (SOCS Protein Family) in Sickle Cell Disease, Graduate School of Natural and Applied Sciences, Mersin University, Continue. 200

    11. Tuğçe Oyahan ÖZCAN, The Investigation of the Effect of Combined Tozasertib and Vitamin-D3 on to the CPC (Chromosomal Passanger Complex) Patway in Leukemic Cells, Graduate School of Natural and Applied Sciences, Mersin University, Continue. 200

    10. Mustafa ÇAĞLAR, The Investigation of the Effect of Combined Tozasertib and Metylprednisolon on to the CPC (Chromosomal Passanger Complex) Patway in Leukemic Cells, Graduate School of Natural and Applied Sciences, Mersin University, 2020, Completed. 200

    9. CENGİZ ÇOLAK, THE INVESTIGATION OF THE EFFECTS OF PAN-AURORA KINASE INHIBITOR DANUSERTIB ON THE mRNA EXPRESSION LEVELS OF CHROMOSOMAL TRANSITION COMPLEX GENES IN PANCREATIC CARCINOMA CELLS, Graduate School of Natural and Applied Sciences, Mersin University, 2019, Completed. 200

    8. YEŞİM TAVŞANOĞLU, Investigation of SOCS-1 Gene Polymorphism from Cytokine Signal Suppressors (SOCS Protein Family) in Sickle Cell Disease, Graduate School of Natural and Applied Sciences, Mersin University, 2019, Completed. 200

    7. LEYLA ERSOY, Investigation of SOCS-1 Gene Polymorphisms in Tuberculosis Patients, Graduate School of Natural and Applied Sciences, Mersin University, 2019, Completed. 200

    6. ERKAN ALABAŞ, THE INVESTIGATION OF THE EFFECT OF DANUSERTIB, A PAN-AURORA KINASE INHIBITOR, ONTO AUTOPHAGY, METASTASİS AND EPİTHELİAL MESENCHYMAL TRANSİTİON (EMT) IN PANCREATIC CANCER CELLS, Graduate School of Natural and Applied Sciences, Mersin University, 2018, Completed. 200

    5. İSMAİL AYBERK KIRBIYIK, THE INVESTIGATION OF THE EFFECT OF DANUSERTIB, A PAN-AURORA KINASE INHIBITOR, ONTO CYTOTOXICITY, CELL CYCLE AND APOPTOSIS IN PANCREATIC CANCER CELLS, Graduate School of Natural and Applied Sciences, Mersin University, 2018, Completed. 200

    4. Hikmet ÇELİK, The investigation of the effect of tozasertibe, a Aurora Kinase-B inhibitor, onto the Chromosomal Passanger Complex (CPC) pathway in Pancreatic Carcinoma Cells., Graduate School of Natural and Applied Sciences, Mersin University, 2015, Completed. 200

    3. Caner KAPLAN, The investigation of the effect of Rho kinase inhibitor Fasudile (HA-1077) in panceratic carcinoma cells (BxPC-3) by evaluating cytotoxicity, apoptosis and metastasis relations, Graduate School of Natural and Applied Sciences, Mersin University, 2015, Completed. 200

    2. Hatice SEVGİ, The investigation of Suppressor of Cytokine Signalling (SOCS-1 and SOCS-3) gene expression levels in the patients with Sickle Cell Anemia, Graduate School of Natural and Applied Sciences, Mersin University, 2012, Completed. 200
    http://www.mersin.edu.tr

    1. Burcu REYHANİ, The İnvestigation of Supressor of Cytokine Signalling (SOCS) Gene Expression in Methyleprednisolone and Vitamine -D3 Treated Chronic Myeloid Leukemia (K-562) Cells, Graduate School of Natural and Applied Sciences, Mersin University, 2011, Completed. 200

    Supervised Doctorate Theses 1600

    4. Hediye KILIÇ, Investigation of the Anti-Cancer Effect of Danusretib, a Pan-Aurora Kinase Inhibitor, in Breast Cancer Epithelial Cells., Graduate School of Natural and Applied Sciences, Mersin University, Continue. 400

    3. İsmail Ayberk KIRBIYIK, The Investigation of the Synergistic Effects of A Pan-Aurora Kinase Inhibitor Danusertib and Caffeic Acid Phenyl Ester (CAPE) on Pancreatic Cancer Cells, Graduate School of Natural and Applied Sciences, Mersin University, Continue. 400

    2. HAMİDE DOĞAN, Investigation of the Effects of Turkish Propolis and Methylprednisolone on Human Acute Myeloid Leukemia (HL-60) Cell, Graduate School of Natural and Applied Sciences, Mersin University, 2021, Completed. 400

    1. Ersin ÖZTÜRK, In-vitro Investigation of Anticancer Effects of Arum dioscoridis Plant Extracts With the Tozasertib onto the CFPAC-1 Pancreatic Carcinoma Cell Line, Graduate School of Natural and Applied Sciences, Mersin University, 2017, Completed. 400
    Supervised_Doctorate_Theses_001.pdf

    International Journal [Year, Count] 25
    1. TURKISH JOURNAL OF BIOLOGY , [ 2015 : 1 ] . 5
    2. TURKISH JOURNAL OF BIOLOGY , [ 2014 : 1 ] . 5
    3. TURKISH JOURNAL OF BIOLOGY , [ 2016 : 2 ] . 10
    4. TURKİSH JOURNAL OF MEDİCAL SCİENCES , [ 2017 : 1 ] . 5
    National Journal [Year, Count] 0
    1. 23. ULUSAL BIYOLOJI KONGRESI , [ 2016 : 20 ] . 0

    National
    1. FINDIKKIRAN BALESİ, DANS GÖSTERİLERİ, MERSİN KÜLTÜR MERKEZİ (800 KİŞİ İZLEYİCİ), ULUDAĞ UNIVERSITY STATE CONSERVATUARY YOUTH SENFONIETTA ORCHESTER and MERSİN UNIVERSTY STATE CONSERVATUARY DEPARTMENT OF BALLET ART, 2016-04-02-2016-04-25, 2 SAAT, BURSA -MERSİN, Turkey
    2. The Boy Friend Müzikali London University Opera Grubu, SAHNE TASARIMI, ULOG London University, University of London Opera Group, 1997-12-01-1997-12-05, 120 dak, London, England / United Kingdom

    National
    1. ULUDAG UNIVERSITY , 2009-07-15 - 2009-08-31, BURSA, Turkey.
    2. ULUDAG UNIVERSITY , 2008-07-15 - 2008-08-31, BURSA, Turkey.
    3. ULUDAG UNIVERSITY , 2007-07-15 - 2007-08-31, BURSA, Turkey.
    4. ULUDAG UNIVERSITY , 2006-07-01 - 2006-08-31, BURSA, Turkey.

    International 0
    1. Grant from Higher Education Council of Turkey Higher Education Counsil, 1993-07-23, Ankara, Turkey. 0
    2. The Best Reviewer Award IAREC 2017 Osmaniye Korkut Ata Üniversitesi, 2017-11-18, Osmaniye, Turkey. 0
    3. jury’s special award World Symposium of Multidisciplinary Research, 2018-11-03, MERSİN, Turkey. 0
    National 25
    1. , 2009-05-27, ANKARA, Turkey. 25

    5. European Association Cancer Research (EACR) , Member No: EACR13236, England / United Kingdom, 2015-12-15-Continue.
    1. Cell Death Research Society (HÖAD) , Member No: 0, Turkey, 2014-09-15-Continue.
    2. The Organization of Molecular Cancer Research (MOKAD) , Member No: 18, Turkey, 2007-12-15-Continue.
    3. Turkish Society of Immunology (TSI) , Member No: 0, Turkey, 2006-12-15-Continue.
    4. The Society of Turkish Medical Biology-Genetics (TBGD) , Member No: 0, Turkey, 2005-11-05-Continue.
    Getting Information
    Strategic Planning
    Bologna Process
    European University Association
    MEU Radio
    Presidential Communication Center
    Osym Provincial Exam Coordinator
    Academic Calendar
    Corporate Internal and External Evaluation Reports
    Graduate Communication
    Green Campus
    Ad Portal

    GENERAL

    Contact

    "A World University In The Light of Science and Modernity"